Washington, D.C.
With clinical research on children rising, the number of independent children’s hospitals awarded accreditation for their human research protection programs has increased nearly three-fold in 2009. Last week three children’s hospitals—Miami Children’s Hospital in Florida, Connecticut Children’s Medical Center in Hartford, and Children’s Healthcare of Atlanta, Inc., in Georgia—joined four other organizations in receiving full accreditation status from the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
Two other independent children’s hospitals—Nationwide Children’s Hospital in Columbus, Ohio, and Nemours, with offices in Wilmington, Delaware, and Florida—achieved accreditation earlier in the year. Cincinnati Children’s Hospital Medical Center and Children’s Hospital Boston had earned accreditation previously, in 2007 and 2005, respectively. In addition, many accredited organizations include children’s hospitals within their organizations’ human protection programs.The seven new accreditations bring the total number of accredited organizations to 194, representing more than 930 entities.
The organizations that were awarded full accreditation are: Children’s Healthcare of Atlanta, Inc. (Atlanta, GA), Connecticut Children’s Medical Center (Hartford, CT), Medical University of South Carolina Charleston, SC, Miami Children’s Hospital (Miami, FL), Ralph H. Johnson VA Medical Center (Charleston, SC), University at Buffalo—State University of New York (Buffalo, NY). The University of Texas Medical Branch at Galveston (Galveston, TX) qualified for accreditation.
The accreditation program utilizes a voluntary, peer-driven educational model. Through the rigorous accreditation process, organizations must demonstrate that they have built extensive safeguards into every level of their research operation and that they adhere to the highest standards for research.The accreditation process typically results in system-wide improvements that enhance protections for research participants and promote high-quality research. For organizations interested in learning more about accreditation, visit http://www.aahrpp.org.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 Diabetes
April 3rd 2025Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease, with benefits consistent with injectable semaglutide and other GLP-1 receptor agonists.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.